je.st
news
Tag: advanced
Rolls-Royce to deliver advanced propulsion equipment to Benetti
2016-05-24 01:00:00| Ship Technology
Rolls-Royce has been selected by Italian yacht builder Benetti to deliver their advanced propulsion equipment that makes use of carbon fibre material for the first time.
Tags: advanced
equipment
deliver
propulsion
Advanced Emissions Solutions Provides Refined Coal Update
2016-05-20 04:47:55| pollutiononline Home Page
Advanced Emissions Solutions, Inc. (OTC PINK:ADES) (the "Company" or "ADES") today announced that Clean Coal Solutions, LLC ("CCS"), a joint venture among the Company's wholly-owned subsidiary ADA-ES, Inc., an affiliate of NexGen Resources Corporation, and an affiliate of The Goldman Sachs Group, Inc., has leased an additional Refined Coal ("RC") facility to anRC investor
Tags: advanced
update
solutions
coal
Lockheed Martin and Indra exhibit advanced radar system for Spanish Navy
2016-05-19 01:00:00| Naval Technology
Lockheed Martin, in collaboration with Indra, has exhibited the first phase of integration of a new solid-state S-band radar system in the US.
Tags: system
advanced
martin
spanish
New KEYTRUDA (pembrolizumab) Data from KEYNOTE-006 and KEYNOTE-001 in Advanced Melanoma, Including Updated Survival Data, To Be Presented at 2016 ASCO Annual Meeting
2016-05-18 23:19:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. Final Overall Survival Data from KEYNOTE-006 To Be Presented at ASCO; KEYTRUDA, the First Anti-PD-1 Monotherapy to Demonstrate Overall Survival Compared to Ipilimumab, Shows Continued Benefit with Longer Follow-Up KEYNOTE-001 Findings Show Continued Benefit in Response Rates, Duration of Response, and Include New Three-Year Overall Survival Data for KEYTRUDA KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced final overall survival (OS) data from KEYNOTE-006 and new findings from KEYNOTE-001, including updated response rates, duration of response data and three-year OS data with KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, in patients with unresectable or metastatic melanoma. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558An Phan, 908-255-6325orInvestors:Teri Loxam, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: including
data
advanced
updated
FotoNation and Kyocera partner on advanced computer vision solutions for automotive
2016-05-18 12:56:18| Green Car Congress
Tags: advanced
computer
partner
solutions
Sites : [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] next »